Deprecated!
This application is deprecated. Please use the latest version of the tool here.
Please cite:
I. S. Vlachos, M. D. Paraskevopoulou, D. Karagkouni, G. Georgakilas, T. Vergoulis, I. Kanellos, I-L. Anastasopoulos, S. Maniou, K. Karathanou, D. Kalfakakou, A. Fevgas, T. Dalamagas and A. G. Hatzigeorgiou. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucl. Acids Res. (2014)
Data Download:
DIANA-TarBase v7 is available for scientific non-profit and non-commercial use! Download TarBase v7 by following this link
|
||||||||
Related Pathways
Publication year
Prediction score
Filters
Selected:
Species: -
Regulation: -
Validation: -
Validated: -
Sources: -
Methods: -
Species: -
Regulation: -
Validation: -
Validated: -
Sources: -
Methods: -
Remove all 

Species

Method Type

Method

Regulation type

Validation type

Validated as

Source

Publication year
Prediction score
Loading...![]() |
Wait until the result set is completed... |
Gene name
miRNA name
Methods
Pred.Score
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:38697457-38697479 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:22179179-22179206 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:22179179-22179206 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:22179188-22179207 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:29257454-29257475 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:29263318-29263342 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:29258824-29258843 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:29263318-29263342 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:29257454-29257475 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr17:29263318-29263342 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:29257454-29257475 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr17:29261575-29261590 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr17:29257454-29257475 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:173955929-173955951 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:173959477-173959503 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:94546487-94546513 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:94546487-94546513 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:85480929-85480943 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr8:85480929-85480943 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:165343038-165343060 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr4:165343038-165343060 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr4:165343038-165343060 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr4:165343038-165343060 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 3 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr4:165343038-165343060 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr4:165343046-165343071 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr4:165343046-165343071 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr4:165343046-165343071 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:4771236-4771256 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:172589509-172589535 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:172589509-172589535 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:172611529-172611549 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:65399290-65399313 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399545-65399565 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399629-65399649 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:65399457-65399481 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399929-65399949 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:65399929-65399949 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:65399545-65399565 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:65398958-65398977 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399457-65399481 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399545-65399565 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399715-65399742 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:65399037-65399061 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399457-65399481 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399545-65399565 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399715-65399742 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399929-65399949 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:65399629-65399649 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:65399929-65399949 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:28281268-28281282 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:28281268-28281282 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:28281268-28281282 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:28281268-28281282 (UNKNOWN)
AGO2 immunoprecipitation with monoclonal anti-AGO2 antibody (Millipore clone 9E8.2).

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:28281268-28281282 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:28281268-28281282 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:28281268-28281282 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:66345756-66345783 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:66345756-66345783 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:66345756-66345783 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:66345756-66345783 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:66345756-66345783 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:66345756-66345783 (UNKNOWN)
Breast carcinoma cell line, triple negative. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:69716720-69716745 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:69716720-69716745 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:69716720-69716745 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:69716720-69716745 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr4:144738033-144738055 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:72910360-72910372 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:72908922-72908940 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:72910360-72910372 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:72910360-72910372 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:72910360-72910372 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:140976621-140976637 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:140979720-140979745 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:140979720-140979745 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:140979720-140979745 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:49633841-49633865 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr20:49633841-49633865 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr20:49636165-49636186 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:57101857-57101884 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr6:57101857-57101884 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr6:57105439-57105461 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr6:57101857-57101884 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:101408201-101408220 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:101409123-101409145 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:244858742-244858768 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:244858742-244858768 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:244854178-244854192 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:207047548-207047560 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:207047563-207047579 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:124522429-124522446 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr9:124517354-124517369 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:124517354-124517369 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:124517291-124517305 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:124517354-124517369 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr15:34379861-34379889 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr15:34379861-34379889 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr15:34379861-34379889 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:86951907-86951928 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:86951907-86951928 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:86951401-86951423 (UNKNOWN)
Primary human umbilical vein endothelium. AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr11:86951907-86951928 (UNKNOWN)
Primary human umbilical vein endothelium. AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:127314832-127314854 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr2:127314832-127314854 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr2:127314832-127314854 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr2:127314832-127314854 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:227655198-227655221 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:227661159-227661177 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:227661159-227661177 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:227654783-227654810 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:227655198-227655221 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:227655282-227655305 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:227654783-227654810 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:227655198-227655221 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:227655450-227655473 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:203441786-203441809 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr2:203428096-203428110 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:23030763-23030781 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr8:23022466-23022479 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr8:23022466-23022479 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:24032222-24032245 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:100386281-100386298 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:100386281-100386298 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:100386281-100386298 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:100386281-100386298 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:100377707-100377727 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:100386281-100386298 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:98579955-98579981 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr3:98579955-98579981 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:49019872-49019897 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:121180402-121180425 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:121180617-121180637 (UNKNOWN)
Primary human umbilical vein endothelium. AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:121180617-121180637 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:50325100-50325120 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr15:77613063-77613088 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:71870236-71870259 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
U2SURP (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:143012302-143012329 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF254 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:24128119-24128145 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:24128119-24128145 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 3 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:24128118-24128136 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:24127707-24127730 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:24128119-24128145 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:24128119-24128145 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:24127791-24127814 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:24128119-24128145 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CHD1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:98901245-98901266 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:98855811-98855832 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:98855999-98856014 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:98855999-98856014 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
VCAN (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:83581571-83581592 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:83581571-83581592 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:83581571-83581592 (UNKNOWN)
Primary human marrow stromal cells (MSS). AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr5:83582195-83582207 (UNKNOWN)
Primary human marrow stromal cells (MSS). AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TRIM32 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:116701062-116701083 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
GPBP1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:57263007-57263026 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:57263007-57263026 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MLLT6 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:38706977-38707004 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF43 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:21807911-21807934 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:21808583-21808603 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21809255-21809269 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:21807651-21807664 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21807827-21807850 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21808163-21808183 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21808583-21808603 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21808751-21808774 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21808835-21808854 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21809087-21809110 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:21807827-21807850 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21808163-21808183 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21808583-21808603 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr19:21808835-21808854 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
EEF1D (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:143590682-143590707 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PINLYP (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:43582101-43582120 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
LTBP3 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:65544147-65544166 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ARFGAP2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:47164687-47164709 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
UHMK1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:162525090-162525110 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:162525090-162525110 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:162525090-162525110 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:162525166-162525182 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CHD7 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr8:60866502-60866522 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr8:60866502-60866522 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr8:60866502-60866522 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr8:60866776-60866792 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
OPA1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:193642998-193643023 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PDDC1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:774086-774113 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF682 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:20006471-20006494 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:20006135-20006149 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
E2F8 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:19224243-19224263 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr11:19224243-19224263 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:19224243-19224263 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:19224243-19224263 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr11:19224243-19224263 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:19224243-19224263 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NDUFA2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:140645520-140645547 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:140645520-140645547 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr5:140645520-140645547 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PHF10 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:169707661-169707681 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr6:169707661-169707681 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr6:169707661-169707681 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
EPS15 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:51356573-51356592 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:51356573-51356592 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:51356573-51356592 (UNKNOWN)
Primary human marrow stromal cells (MSS). AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF518A (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:96162383-96162404 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:96156839-96156861 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
OSTM1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:108165652-108165678 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
WNK1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:909461-909478 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr12:896449-896465 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF273 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:64928104-64928122 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64928104-64928122 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64917653-64917675 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64928104-64928122 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64928687-64928710 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64928104-64928122 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64928957-64928971 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64928687-64928710 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF85 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:20949189-20949212 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:20949189-20949212 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TNRC6B (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr22:40323795-40323816 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr22:40264786-40264802 (UNKNOWN)
Primary human umbilical vein endothelium. AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr22:40323490-40323517 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr22:40323490-40323517 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
GPSM1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:136358542-136358557 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HDHD3 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:113375981-113375997 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF680 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:64522116-64522134 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64520233-64520256 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64521108-64521127 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64521612-64521631 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64520233-64520256 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64521016-64521034 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64521108-64521127 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64521612-64521631 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64520233-64520256 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64521108-64521127 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64521359-64521379 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NACC2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:136011392-136011409 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:136008880-136008897 (UNKNOWN)
AGO2 immunoprecipitation with monoclonal anti-AGO2 antibody (Millipore clone 9E8.2).

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:136011392-136011409 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:136008880-136008897 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
BMPR2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:202561794-202561810 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr2:202519015-202519036 (UNKNOWN)
Primary human umbilical vein endothelium. AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
IREB2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr15:78476317-78476335 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr15:78476317-78476335 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr15:78466381-78466397 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr15:78476317-78476335 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr15:78476317-78476335 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr15:78476317-78476335 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr15:78476317-78476335 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
GULP1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:188595282-188595300 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ACADM (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:75749454-75749476 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TUBB4B (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr9:137243246-137243266 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:137243246-137243266 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr9:137243246-137243266 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:137243246-137243266 (UNKNOWN)
Primary human umbilical vein endothelium. AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:137243246-137243266 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr9:137243246-137243266 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
NME1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr17:51161099-51161119 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
DNAJA2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:46964768-46964790 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
OSBPL8 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:76352281-76352307 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr12:76352281-76352307 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZIC5 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr13:99963609-99963632 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr13:99963609-99963632 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr13:99963819-99963832 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
PPA1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr10:70217889-70217909 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:70217889-70217909 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:70217889-70217909 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:70217889-70217909 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:70217889-70217909 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:70217889-70217909 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr10:70217889-70217909 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
TNRC6A (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr16:24825371-24825379 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24825371-24825379 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24823966-24823993 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24825371-24825379 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24825371-24825379 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24825371-24825379 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24825371-24825379 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24823966-24823993 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24823966-24823993 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24823966-24823993 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
Primary human marrow stromal cells (MSS). AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
AGO2 immunoprecipitation with monoclonal anti-AGO2 antibody (Millipore clone 9E8.2).

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24825371-24825379 (UNKNOWN)
AGO2 immunoprecipitation with monoclonal anti-AGO2 antibody (Millipore clone 9E8.2).

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24825371-24825379 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
Pancreatic Islets. AGO2 immunoprecipitation using HITS-CLIP antibody: Argonaute antibody 2A9

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24791678-24791700 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24823966-24823993 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
LCL-BACD3 lymphoblastoid cells infected by EBV B95-8 BACmid. LCL-BAC-D1 cells were generated from the same donor as LCL-BAC and are mutationally inactivated for miR-BHRF1-3 expression. antibody: Anti-Ago2 (clone 9E8).

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24823966-24823993 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr16:24825608-24825624 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr16:24825608-24825624 (UNKNOWN)
AGO2 immunoprecipitation with anti-AGO2 mAb, clone 2E12-1C9(Abnova) antibody

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
UBAP2L (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:154243267-154243283 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:154228629-154228655 (UNKNOWN)
Primary human umbilical vein endothelium. AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr1:154243267-154243283 (UNKNOWN)
Primary human umbilical vein endothelium. AGO2 immunoprecipitation using anti-Ago2 antibod 2A8

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CPVL (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:28995525-28995545 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FASTKD5 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr20:3148971-3148989 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr20:3149226-3149242 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
DDX39B (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:31536519-31536536 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr6:31530409-31530436 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr6:31530409-31530436 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
XXbac-BPG32J3.20 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr6:31691634-31691653 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
HDLBP (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:241249911-241249938 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ELMSAN1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr14:73715206-73715226 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr14:73715283-73715301 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr14:73715206-73715226 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 3 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr14:73715206-73715226 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr14:73715283-73715301 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr14:73715283-73715301 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
USP5 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:6866490-6866512 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
DNAJB1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:14515517-14515533 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SDF2L1 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr22:21644255-21644279 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ACVR2B (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr3:38490642-38490666 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
FAM122B (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chrX:134771135-134771157 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
CCSAP (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:229321034-229321049 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:229321034-229321049 (UNKNOWN)
B cell lines infected by KSHV virus. AGO Immunoprecipitation using anti-Argonaute 2A8. 4 replicates available

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF622 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr5:16463703-16463722 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ABHD2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr15:89197917-89197944 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr15:89197425-89197443 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZNF107 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr7:64707272-64707296 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64707272-64707296 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64707272-64707296 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64709522-64709540 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64709195-64709218 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64706769-64706792 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64706857-64706876 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64709368-64709387 (UNKNOWN)
Primary effusion lymphoma cell line BC-1

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64709458-64709472 (UNKNOWN)
Primary effusion lymphoma cell line BC-3

PAR-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64706857-64706876 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64707272-64707296 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64707445-64707464 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64707614-64707641 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64708113-64708136 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64708365-64708388 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64708453-64708472 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64708696-64708717 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64709458-64709472 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64707614-64707641 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64707693-64707716 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64707945-64707968 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64708113-64708136 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64708365-64708388 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64708453-64708472 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64708617-64708640 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64708864-64708886 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64709522-64709540 (UNKNOWN)
Breast carcinoma cell line, Her2 amplified. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr7:64708617-64708640 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
chr7:64709458-64709472 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
SPRED2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr2:65432066-65432086 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
MAP2K5 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr15:67543294-67543319 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
LMNB2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr19:2430911-2430937 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr19:2429951-2429977 (UNKNOWN)
AGO2 immunoprecipitation using anti-Ago2 antibody (Abcam AB57113). This antibody also recognizes Ago1 and Ago3. HIV-1 (strain: WT/BaL) infected Cervical Epithelial Cell Line, HeLa derivative. Length of infection (days): 3.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ANGEL2 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr1:213008376-213008393 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Abnova, antibody catalog #: H00027161-M01).Treatment protocol: treated with 1 mM sodium arsenite for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:213008376-213008393 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Sigma).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr1:213008376-213008393 (UNKNOWN)
Breast carcinoma cell line, estrogen receptor positive. 3 replicates available.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
ZBED5 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr11:10853457-10853477 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
Location
Method
Result
Regulation
Valid. type
Source
chr11:10853457-10853477 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 1 μM hippuristanol for 30 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0
E2F7 (hsa) 

hsa-miR-23a-3p 


-
Publication
Methods
Tissue
Cell line
Tested cell line
Exp. condition
Location
Method
Result
Regulation
Valid. type
Source
chr12:77023008-77023032 (UNKNOWN)
AGO2 immunoprecipitation (antibody manufacturer: Santa Cruz).Treatment protocol: treated with 20 μg/mL emetine for 60 minutes.

HITS-CLIP
POSITIVE

DIRECT
Tarbase 7.0